IL6 and autoimmune disease: Moreover, psoriasis is characterized by increased expression of TNF-α and IL-6 in lesions [44], and TNF-α is a verified drug target in psoriasis [45, 46] and other autoimmune diseases, such as inflammatory bowel disease (IBD) [47] and RA [48].